HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy
{{output}}
This study investigated, for the first time, the association between HER2 expression, immune infiltration inferred by CIBERSORTx, and immunotherapy response in HER2-negative early breast cancer (EBC). Gene expression was analyzed in prospective discovery (n = ... ...
